From top: Director General, HSE Tony O’Brien and Minister for Health Simon Harris TD at the launch of the National Services Plan 2018; ‘Evofem Biosciences’ logo.
Via Irish Times:
Minister for Health Simon Harris gave written consent to HSE director general Tony O’Brien to take up a lucrative role at a US contraceptive manufacturer months before he leaves his role running the country’s health service, the HSE has said.
Mr O’Brien became a board member of the San Diego company Evofem Biosciences on January 17th, almost two months before he publicly announced he would be leaving the HSE in August.
His boardroom roles at the publicly quoted company entitles him to an “annual cash retainer” of $50,000, additional cash fees of $15,000 and initial share-buying options worth $180,000 vesting over a three-year period with further annual options of $90,000, according to the firm’s public statements.
Mr O’Brien is paid an annual salary of €192,000 as HSE director-general, a job he said in March he will leave at the end of the summer.
Last night: Emma’s Story